References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. American Psychiatric Association, Washington(DC) 1980
- Aronson T. A. Is panic disorder a distinct diagnostic entity? A critical review of the borders of a syndrome. J Nerv Ment Dis 1987; 175: 584–94
- Roth M., Argyle N. Anxiety, panic and phobic disorders: an overview. J Psychiatr Res 1988; 22(Suppl 1)33–54
- Rosenberg R., Ottosson J. O., Bech P. Validation criteria for panic disorder as a nosological entity. Acta Psychiatr Scand 1991; 365 Suppl: 7–17
- Sheehan D., Ballenger J. C., Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980; 37: 51–9
- Carr D., Sheehan D. Panic anxiety: a new biological model. J Clin Psychiatry 1984; 8: 323–30
- Liebowitz M. R., Fyer A. J., Gorman J. M. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. J Psychiatr Res 1988; 22(Suppl 1)7–32
- Ballenger J. C., Burrows G. D., DuPont RLJ. Alprazolam in panic disorder and agoraphobia: results from a multicenter study. Arch Gen Psychiatry 1988; 45: 413–22
- Cross-National Collaborative Panic Study, Second Phase Investigators. Drug treatment of panic disorder. Comparative efficacy of alprazolam. Br J Psychiatry 1992; 160: 191–202
- Rosenberg N. K., MellergSrd M., Rosenberg R. Characteristics of panic disorder patients responding to placebo. Acta Psychiatr Scand 1991; 365(Suppl)33–8
- Klerman G. L. Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 1988; 45: 407–12
- Rosenberg NK, Rosenberg R. Three-year follow-up of panic disorder patients. Scand J Psychol 1993, In press.
- Wilkinson G., Balestrieri M., Ruggeri M. Meta-analysis of double-blind placebo-controlled trials of antidepressants. Psychol Med 1991; 21: 991–8
- Sheehan D. V., Raj A. Benzodiazepine treatment of panic disorder. Handbook of anxiety, R. Noyes, M. Roth, G. D. Burrows. Elsevier, Amsterdam 1990; 169–206
- Matuzas W., Jack E. The drug treatment of panic disorder. Psychiatr Med 1991; 9: 215–43
- Marks I., Greist J., Basoglu M. Comment on the second phase of the Cross-National Collaborative Panic Study. Br J Psychiatry 1992; 160: 202–5
- Clark D. B., Taylor C. B., Roth W. T. Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 1990; 147: 507–9
- Dager S. R., Khan A., Cowley D. Characteristics of placebo response during long-term treatment of panic disorder. Psychopharmacol Bull 1990; 26: 273–8
- Scheibe G., Nutzinger D., Buller R. Pretreat-ment anxiety level as differential predictor in outpatients with panic disorder. Arzneimittelforsch 1992; 42: 1090–4
- Maier W., Roth S. M., Argyle N. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder. Eur Arch Psychiatr Clin Neurosci 1991; 241: 151–8
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. American Psychiatric Association, Washington, DC 1987
- Deltito J. A., Argyle N., Klerman G. L. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J Clin Psychiatry 1991; 52: 121–7
- Reich J. The effect of personality on placebo response in panic patients. J Nerv Ment Dis 1990; 178: 699–702
- Noyes R., Riech J. H., Suelzer M. Personality traits associated with panic disorder: change associated with treatment. Compr Pscychiatry 1991; 32: 283–94
- Mellergård M., Rosenberg N. K. Patterns of response during placebo treatment of panic disorder. Acta Psychiatr Scand 1990; 81: 340–4
- Albus M., Lecrubier Y., Maier W. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Acta Psychiatr Scand 1990; 82: 359–65
- Coryell W., Noyes R. HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry 1988; 24: 762–6
- Johnson J., Weissman M. M., Klerman G. L. Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry 1990; 47: 805–8
- Markowitz J. S., Weissman M. M., Oueliette R. Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46: 984–92
- Lelliott P. T., Marks I. M., Monteiro W. O. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors. J Nerv Ment Dis 1987; 175: 599–605
- McNally R. Psychological approaches to panic disorder: a review. Psychol Bull 1990; 108: 403–19
- Breier A., Charney D. S., Heninger G. R. Agoraphobia with panic attacks: development, diagnostic stability, and course of illness. Arch Gen Psychiatry 1986; 43: 1029–36
- Mavissakalian M. The placebo effect in agoraphobia. J Nerv Ment Dis 1987; 175: 95–9
- Mavissakalian M. The placebo effect in agoraphobia. II. J Nerv Ment Dis 1988; 176: 446–8
- Shapiro A. K., Morris L. A. The placebo effect in medical and psychological therapies. Handbook of psychotherapy and behavioral change, S. L. Garfield, A. E. Bergin. Wiley, New York 1978; 369–410
- Klosko J. S., Barlow D. H., Tassinari R. A comparison of alprazolam and behaviour therapy in treatment of panic disorder. J Consult Clin Psychol 1990; 58: 77–84